HCM
Price
$10.77
Change
-$0.62 (-5.44%)
Updated
Jul 30 closing price
Capitalization
2B
Intraday BUY SELL Signals
UPC
Price
$3.48
Change
+$0.22 (+6.75%)
Updated
Jul 30 closing price
Capitalization
2.25M
Intraday BUY SELL Signals
Interact to see
Advertisement

HCM vs UPC

HCM vs UPC Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
HCM vs. UPC commentary
Jul 31, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HCM is a StrongBuy and UPC is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 31, 2026
Stock price -- (HCM: $10.77 vs. UPC: $3.48)
Brand notoriety: HCM and UPC are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HCM: 56% vs. UPC: 1%
Market capitalization -- HCM: $2B vs. UPC: $2.25M
HCM [@Pharmaceuticals: Generic] is valued at $2B. UPC’s [@Pharmaceuticals: Generic] market capitalization is $2.25M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HCM’s FA Score shows that 2 FA rating(s) are green whileUPC’s FA Score has 2 green FA rating(s).

  • HCM’s FA Score: 2 green, 3 red.
  • UPC’s FA Score: 2 green, 3 red.
According to our system of comparison, both HCM and UPC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HCM’s TA Score shows that 3 TA indicator(s) are bullish while UPC’s TA Score has 4 bullish TA indicator(s).

  • HCM’s TA Score: 3 bullish, 6 bearish.
  • UPC’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, both HCM and UPC are a bad buy in the short-term.

Price Growth

HCM (@Pharmaceuticals: Generic) experienced а -1.73% price change this week, while UPC (@Pharmaceuticals: Generic) price change was -8.18% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.14%. For the same industry, the average monthly price growth was -3.72%, and the average quarterly price growth was +19.40%.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.14% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HCM($2B) has a higher market cap than UPC($2.25M). UPC YTD gains are higher at: -8.661 vs. HCM (-19.205). HCM has higher annual earnings (EBITDA): 38M vs. UPC (-15.83M). HCM has more cash in the bank: 1.37B vs. UPC (8.86M). UPC has less debt than HCM: UPC (6.51M) vs HCM (93.4M). HCM has higher revenues than UPC: HCM (602M) vs UPC (26.7M).
HCMUPCHCM / UPC
Capitalization2B2.25M88,864%
EBITDA38M-15.83M-240%
Gain YTD-19.205-8.661222%
P/E Ratio108.20N/A-
Revenue602M26.7M2,255%
Total Cash1.37B8.86M15,403%
Total Debt93.4M6.51M1,435%
FUNDAMENTALS RATINGS
HCM: Fundamental Ratings
HCM
OUTLOOK RATING
1..100
42
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
21
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HCMUPC
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend 9 days ago
79%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
HCM
Daily Signal:
Gain/Loss:
UPC
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZURA5.540.23
+4.33%
Zura Bio Limited
NRXS6.280.24
+3.97%
Neuraxis
WLYB52.931.03
+1.98%
John Wiley & Sons
REG80.36-0.75
-0.92%
Regency Centers Corp
SUGP0.47N/A
-1.04%
SU Group Holdings Limited

HCM and

Correlation & Price change

A.I.dvisor tells us that HCM and ACET have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HCM and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HCM
1D Price
Change %
HCM100%
-5.44%
ACET - HCM
29%
Poorly correlated
+9.16%
TLRY - HCM
27%
Poorly correlated
+5.26%
CGC - HCM
27%
Poorly correlated
+3.20%
GELS - HCM
25%
Poorly correlated
-4.06%
SNDL - HCM
25%
Poorly correlated
+4.17%
More

UPC and

Correlation & Price change

A.I.dvisor indicates that over the last year, UPC has been loosely correlated with BIOA. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if UPC jumps, then BIOA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UPC
1D Price
Change %
UPC100%
+6.91%
BIOA - UPC
50%
Loosely correlated
+11.99%
TXMD - UPC
22%
Poorly correlated
-1.46%
HCM - UPC
21%
Poorly correlated
-5.44%
PRFX - UPC
21%
Poorly correlated
+3.94%
CTOR - UPC
15%
Poorly correlated
+5.17%
More